← All trials
NCT00280111
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2005
- Primary completion
- May 1, 2005
- Completion date
- May 1, 2005
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Society for Applied Studies, New DelhiLead sponsor
- Stanford UniversityCollaborator
- Indian Institute of ScienceCollaborator
- University of CincinnatiCollaborator
- All India Institute of Medical SciencesCollaborator
- All India Institute of Medical SciencesOverall official - principal investigator
- National Institutes of Health (NIH)Collaborator
- Government of IndiaCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- PATHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.